4 completed, 2 recruiting, 2 terminated, 1 not yet recruiting. 10 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 4, Recruiting 2, Terminated 2, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Adult: new trials by email Literature Review of Adult trials Research Report on Adult
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inotuzumab as Post-Trasplantation Therapy for Adult High-risk B-cell Precursor Acute Lymphoblastic Leukemia Inotuzumab Ozogamicin (IO) - Acute Lymphobkastic Leukemia, Adult | Phase 2 | Not yet recruiting | PETHEMA Foundation | 30 | 2026-10-30 | 2026-10-07 |
| A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma HF1K16 - Glioma, Adult | Phase 2 | Recruiting | HighField Biopharmaceuticals Corporation | 30 | 2026-06-30 | 2026-07-10 |
| Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer GT101 injection, Gemcitabine injection - Adult | Phase 2 | Recruiting | Grit Biotechnology | 83 | 2024-04-02 | 2026-04-15 |
| Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults venetoclax combined with azacitidine - Myelodysplastic/Myeloproliferative Neoplasms, Adult | Phase 2 | Unknown | The First Affiliated Hospital of Soochow University | 33 | 2022-04-01 | 2022-03-16 |
| Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS - SYSTEMIC SCLERODERMA, ALLOGENEIC MESENCHYMAL STEM CELLS | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 20 | 2014-05-06 | 2024-05-01 |
| Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock. hydrocortison hemisuccinate, placebo followed by hydrocortisone hemisuccinate - Septic Shock, Adult | Phase 2 / Phase 3 | Terminated | Centre Hospitalier Régional d'Orléans | 10 | 2013-11-05 | 2020-02-11 |
| Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury Elliptical exercise - Adult, Traumatic Brain Injury | Phase 1 / Phase 2 | Completed | National Institutes of Health Clinical Center (CC) | 34 | 2011-08-24 | 2026-10-16 |
| Efficacy of Mindful Tai Chi on Obese or Overweight Adults: A Randomized Controlled Clinical Trial Mindful Tai Chi Intervention, Mindfulness Meditation, Mall Walking - Obesity, Adult | Phase 2 | Terminated | National Institute of Nursing Research (NINR) | 25 | 2010-12-09 | 2019-11-29 |
| Development and Evaluation of a Nursing Virtual Intervention Tailored for Pain After Cardiac Surgery soulageTAVIE - Cardiac Surgery, Pain | Phase 1 / Phase 2 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 60 | 2010-02-01 | 2010-09-15 |
| SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial SU011248, Placebo - Urothelial Cancer, Bladder Cancer | Phase 2 | Completed | AHS Cancer Control Alberta | 64 | 2008-04-01 | 2018-08-22 |
Agnosia (1) · Brain Injuries, Traumatic (1) · Glioma (1) · Myelodysplastic-Myeloproliferative Diseases (1) · Obesity (1) · Overweight (1) · Pain (1) · Pain, Postoperative (1) · Recurrence (1) · Scleroderma, Systemic (1) · Shock, Septic (1) · Stress Disorders, Post-Traumatic (1) · Urinary Bladder Neoplasms (1)
Pathological Conditions, Signs and Symptoms (4) · Pathologic Processes (3) · Neoplasms (2) · Nervous System Diseases (2) · Signs and Symptoms (2) · Body Weight (1) · Bone Marrow Diseases (1) · Brain Diseases (1) · Brain Injuries (1) · Central Nervous System Diseases (1) · Connective Tissue Diseases (1) · Craniocerebral Trauma (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Azacitidine (1) · Gemcitabine (1) · Inotuzumab Ozogamicin (1) · Mindfulness (1) · Sunitinib (1) · dimethyl-2-(tetrahydro-2-furanyl)ethylsulfonium (1)
AHS Cancer Control Alberta (1) · Assistance Publique - Hôpitaux de Paris (1) · Centre Hospitalier Régional d'Orléans (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Grit Biotechnology (1) · HighField Biopharmaceuticals Corporation (1) · National Institute of Nursing Research (NINR) (1) · National Institutes of Health Clinical Center (CC) (1) · PETHEMA Foundation (1) · The First Affiliated Hospital of Soochow University (1)
China (3) · Canada (2) · France (2) · United States (2) · Spain (1)
Raymond A Dionne, D.D.S. (1) · Silvina G Horovitz, Ph.D. (1) · Suning Chen, Professor (1) · Thierry Boulain, MD (1) · Tina Cheng, M.D. (1)